Lista de obras - Richard Ceska - Dominio Público Uruguay

2P-0477 Leukocyte but not endothelial cell adhesion molecules are increased in patients with hypercholesterolemia: The effect of atorvastatin treatment

3P-0742 APOAV polymorphisms (T-1131/C and Ser19/Trp) influence on plasma triglyceride levels and risk of myocardial infarction

article published in 2003

3P-0795 Apolipoprotein AV polymorphism is the only genetic marker associated with severe hypertriglyceridemia. Results of analysis of four gene loci

article

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels

artículo científico publicado en 2008

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

artículo científico publicado en 2000

Apoe genotype is not associated with variations in bone mineral density

Apolipoprotein E polymorphism in patients with different types of hyperlipidemia

Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population

article

Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia.

artículo científico publicado en 2003

CARDIOVASCULAR RISK ASSESSMENT BY ATHEROGENIC INDEX OF PLASMA [LOG(TG/HDL-C)]

Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission

artículo científico publicado en 2005

Clinical implications of the metabolic syndrome

artículo científico publicado en 2007

Decreasing common carotid artery intimal thickness during hypolipidemic therapy

artículo científico publicado en 1997

Detection of variability in apo(a) gene transcription regulatory sequences using the DGGE method

scientific article published on 21 July 2006

Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?

artículo científico publicado en 2011

Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.

artículo científico publicado en 2003

Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes

artículo científico publicado en 2004

Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

artículo científico publicado en 2010

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study

artículo científico publicado en 2014

FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention

article

Familial defective apolipoprotein B-100 homozygote with premature coronary atherosclerosis. A case report 1

artículo científico publicado en 1999

Flow-dependent vasomotor dysfunction of the popliteal artery related to common carotid artery intima-media thickness.

artículo científico publicado en 2001

Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy.

artículo científico publicado en 2001

Folic acid does not improve surrogate markers of early atherosclerosis in atorvastatin-treated patients

Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men

article

Hypertriglyceridemia: interaction between APOE and APOAV variants.

artículo científico publicado en 2005

IMPACT OF APOLIPOPROTEIN A5 GENE VARIANTS ON STATIN TREATMENT EFFICACY

article

Impact of apolipoprotein A5 variants on statin treatment efficacy

artículo científico publicado en 2009

Increase of inflammatory state in overweight adults with combined hyperlipidemia.

artículo científico publicado en 2003

Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment.

artículo científico publicado en 2003

Is it safe to combine PPAR agonists? A lesson from muraglitazar

artículo científico publicado en 2006

Ivabradine, coronary heart disease, and heart failure: time for reappraisal.

artículo científico publicado en 2014

LIPID PROFILE AND LP(A) IN FIT AND HEALTHY ELDERLY

MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe

article by Michal Vrablík et al published 23 October 2008 in Human Genetics

Mo-P6:430 Lipoprotein (A), its relation to gene control regions

article

New strategies in the treatment of dyslipidemia: do we know how?

artículo científico publicado en 2004

Nitroglycerin induced syncope occurs in subjects with delayed phase shift of baroreflex action.

artículo científico publicado en 2002

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

artículo científico publicado en 2015

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.

artículo científico publicado en 2008

PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP.

artículo científico publicado en 2003

PO22-705 ESTROGEN REPLACEMENT THERAPY LOWERS RLP CONCENTRATION: ORAL AND TRANSDERMAL ADMINISTRATION COMPARED

PO6-168 APOLIPOPROTEIN AV GENE SNPS DETERMINATION IN PATIENTS GROUP WITH HIGH TRIGLYCERIDES LEVELS

article

PO6-175 CONTROL GENE REGIONS OF LIPOPROTEIN (A): ASSOCIATION WITH LONGEVITY

article

Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: data from the MedPed CZ database and the Czech population.

artículo científico publicado en 2011

Prevention of diabetes with rosiglitazone: Evidence of benefit or unexpected harm?

scientific article published on 12 September 2007

ROSIGLITAZONE AND FENOFIBRATE IMPROVE HDL METABOLISM ASSESSED BY FERHDL

Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy

artículo científico publicado en 2012

SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population

artículo científico publicado en 2015

Serum leptin levels in patients with hyperlipidemias

artículo científico publicado en 2000

Statin Intolerance: the Clinician's Perspective

artículo científico publicado en 2015

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel

artículo científico publicado en 2015

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

article

Statins, glycemia, and diabetes mellitus: another point of view

artículo científico

T04-P-048 Liprotein (a), its relation to plasmalipids and other risk factors for atherosclerosis

article published in 2005

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient

artículo científico publicado en 2008

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

artículo científico publicado en 2008

The apo(a) gene (TTTTA)n promoter polymorphism and its association with variability in exons of the kringle IV types 8 to 10.

artículo científico publicado en 2009

The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.

artículo científico

Type III hyperlipoproteinaemia in patient with severe hypothyroidism accompanied by primary amenorrhoea

Use of the D19S394 tetranucleotide repeat in the diagnosis of familial hypercholesterolemia

Variability in apo(a) gene regulatory sequences, compound genotypes, and association with Lp(a) plasma levels

artículo científico publicado en 2007

Variant within CELSR2/PSRC1/SORT1, but not within CILP2/PBX4, PCSK9 and APOB genes, has a potential to influence statin treatment efficacy

article

W06-O-003 APOE and APOAV polymorphisms — No interaction in hypertriglyceridaemia

W06-P-006 Apolipoprotein AV gene SNP determination in patients with high triglyceride levels

article

Lista de obras de Richard Ceska

2P-0477 Leukocyte but not endothelial cell adhesion molecules are increased in patients with hypercholesterolemia: The effect of atorvastatin treatment

3P-0742 APOAV polymorphisms (T-1131/C and Ser19/Trp) influence on plasma triglyceride levels and risk of myocardial infarction

3P-0795 Apolipoprotein AV polymorphism is the only genetic marker associated with severe hypertriglyceridemia. Results of analysis of four gene loci

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

Apoe genotype is not associated with variations in bone mineral density

Apolipoprotein E polymorphism in patients with different types of hyperlipidemia

Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech population

Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia.

CARDIOVASCULAR RISK ASSESSMENT BY ATHEROGENIC INDEX OF PLASMA [LOG(TG/HDL-C)]

Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission

Clinical implications of the metabolic syndrome

Decreasing common carotid artery intimal thickness during hypolipidemic therapy

Detection of variability in apo(a) gene transcription regulatory sequences using the DGGE method

Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?

Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.

Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes

Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study

FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention

Familial defective apolipoprotein B-100 homozygote with premature coronary atherosclerosis. A case report 1

Flow-dependent vasomotor dysfunction of the popliteal artery related to common carotid artery intima-media thickness.

Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy.

Folic acid does not improve surrogate markers of early atherosclerosis in atorvastatin-treated patients

Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men

Hypertriglyceridemia: interaction between APOE and APOAV variants.

IMPACT OF APOLIPOPROTEIN A5 GENE VARIANTS ON STATIN TREATMENT EFFICACY

Impact of apolipoprotein A5 variants on statin treatment efficacy

Increase of inflammatory state in overweight adults with combined hyperlipidemia.

Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment.

Is it safe to combine PPAR agonists? A lesson from muraglitazar

Ivabradine, coronary heart disease, and heart failure: time for reappraisal.

LIPID PROFILE AND LP(A) IN FIT AND HEALTHY ELDERLY

MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe

Mo-P6:430 Lipoprotein (A), its relation to gene control regions

New strategies in the treatment of dyslipidemia: do we know how?

Nitroglycerin induced syncope occurs in subjects with delayed phase shift of baroreflex action.

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.

PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP.

PO22-705 ESTROGEN REPLACEMENT THERAPY LOWERS RLP CONCENTRATION: ORAL AND TRANSDERMAL ADMINISTRATION COMPARED

PO6-168 APOLIPOPROTEIN AV GENE SNPS DETERMINATION IN PATIENTS GROUP WITH HIGH TRIGLYCERIDES LEVELS

PO6-175 CONTROL GENE REGIONS OF LIPOPROTEIN (A): ASSOCIATION WITH LONGEVITY

Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: data from the MedPed CZ database and the Czech population.

Prevention of diabetes with rosiglitazone: Evidence of benefit or unexpected harm?

ROSIGLITAZONE AND FENOFIBRATE IMPROVE HDL METABOLISM ASSESSED BY FERHDL

Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy

SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population

Serum leptin levels in patients with hyperlipidemias

Statin Intolerance: the Clinician's Perspective

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

Statins, glycemia, and diabetes mellitus: another point of view

T04-P-048 Liprotein (a), its relation to plasmalipids and other risk factors for atherosclerosis

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

The apo(a) gene (TTTTA)n promoter polymorphism and its association with variability in exons of the kringle IV types 8 to 10.

The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.

Type III hyperlipoproteinaemia in patient with severe hypothyroidism accompanied by primary amenorrhoea

Use of the D19S394 tetranucleotide repeat in the diagnosis of familial hypercholesterolemia

Variability in apo(a) gene regulatory sequences, compound genotypes, and association with Lp(a) plasma levels

Variant within CELSR2/PSRC1/SORT1, but not within CILP2/PBX4, PCSK9 and APOB genes, has a potential to influence statin treatment efficacy

W06-O-003 APOE and APOAV polymorphisms — No interaction in hypertriglyceridaemia

W06-P-006 Apolipoprotein AV gene SNP determination in patients with high triglyceride levels

W06-P-009 Type V hyperlipoproteinaemia: APOAV polymorphism as genetic background

We-P11:117 Rosiglitazone improves quality of lipoproteins in patients with type 2 diabetes

We-P12:278 Estrogen replacement therapy decreases RLP concentration in plasma: Oral and transdermal ERT comparison